A corticosteroid ester with marked topical effect; this property is made use of in bronchial inhalation.
Beclometasone controls the rate of protein synthesis, depresses the migration of polymorphonuclear leukocytes and fibroblasts, and reverses capillary permeability and lysosomal stabilization at the cellular level to prevent or control inflammation.

Topical
Corticosteroid-responsive dermatoses, 0.025% cream/oint: apply as directed.

Inhalation
Asthma prophylaxis. Initial: 600-800 mcg/day. Maintenance: 400 mcg/day in divided doses.
Severe asthma 250 mcg 4 times/day. Max: 2 mg/day.
Nasal allergic and non-allergic rhinitis 100 mcg into each nostril twice daily. Max: 400 mcg/day.

Indications in palliative care: reversible and irreversible airways obstruction, stridor, lymphangitis carcinomatosa, radiation pneumonitis, cough after insertion of bronchial stent.

CIMS Drug Information System. Internet. Accessed on January 10, 2016.